Stock Scorer

BioCardia, Inc. (BCDA)

BioCardia, Inc. reported revenue of 0 USD for the quarter ending 31 December 2025.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q4 '25 · ending 31 December 2025 0 —
Gross Profit Q2 '13 · ending 30 June 2013 69K +305.9%
Operating Income Q2 '26 · ending 30 June 2026 -1.6M —
Net Income Q2 '26 · ending 30 June 2026 -1.6M —
Cost of Revenue Q4 '21 · ending 31 December 2021 0 —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -1.7M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -1.7M —
Shares Outstanding Q2 '26 · ending 30 June 2026 12.1M +160.9%
EPS Q2 '26 · ending 30 June 2026 -0.64 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 0-8.3M-8.2M-7.4M
20242024-12-31 58K-8M-7.9M-7.9M
20232023-12-31 477K-11.6M-11.6M-10M
20222022-12-31 1.4M-11.9M-11.9M-10.6M
20212021-12-31 1M-12.6M-12.6M-10.5M
20202020-12-31 145K-15.5M-15M-12.4M
20192019-12-31 710K-14.2M-14.7M-9.6M
20182018-12-31 625K-14.1M-14M-11.1M
20172017-12-31 479K-12.4M-12.3M-8.8M
20162016-12-31 576K-7.6M-10.3M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q4 '252025-12-310
Q3 '252025-09-300
Q2 '252025-06-300
Q1 '252025-03-310
Q4 '242024-12-310
Q3 '242024-09-300
Q2 '242024-06-303K
Q1 '242024-03-3155K
Q4 '232023-12-3113K
Q3 '232023-09-30357K
Q2 '232023-06-3043K
Q1 '232023-03-3164K
Q4 '222022-12-31106K
Q3 '222022-09-30212K
Q2 '222022-06-30974K
Q1 '222022-03-3160K
Q4 '212021-12-3179K
Q3 '212021-09-30821K
Q2 '212021-06-3069K
Q1 '212021-03-3146K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '132013-06-3069K
Q1 '132013-03-3138K
Q4 '122012-12-3115K
Q3 '122012-09-3019K
Q2 '122012-06-3017K
Q1 '122012-03-3111K
Q4 '112011-12-3112K
Q3 '112011-09-300
Q2 '112011-06-300
Q1 '112011-03-310
Q4 '102010-12-310
Q3 '102010-09-300
Q2 '102010-06-300
Q1 '102010-03-310

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-1.6M
Q1 '262026-03-31-2.3M
Q4 '252025-12-31-2M
Q3 '252025-09-30-1.5M
Q2 '252025-06-30-2.1M
Q1 '252025-03-31-2.7M
Q4 '242024-12-31-2.3M
Q3 '242024-09-30-1.8M
Q2 '242024-06-30-1.6M
Q1 '242024-03-31-2.3M
Q4 '232023-12-31-2.1M
Q3 '232023-09-30-2.6M
Q2 '232023-06-30-3.5M
Q1 '232023-03-31-3.5M
Q4 '222022-12-31-3M
Q3 '222022-09-30-3.1M
Q2 '222022-06-30-2.5M
Q1 '222022-03-31-3.3M
Q4 '212021-12-31-3.5M
Q3 '212021-09-30-2.7M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-1.6M
Q1 '262026-03-31-2.3M
Q4 '252025-12-31-2M
Q3 '252025-09-30-1.5M
Q2 '252025-06-30-2M
Q1 '252025-03-31-2.7M
Q4 '242024-12-31-2.3M
Q3 '242024-09-30-1.7M
Q2 '242024-06-30-1.6M
Q1 '242024-03-31-2.3M
Q4 '232023-12-31-2.1M
Q3 '232023-09-30-2.6M
Q2 '232023-06-30-3.4M
Q1 '232023-03-31-3.5M
Q4 '222022-12-31-3M
Q3 '222022-09-30-3.1M
Q2 '222022-06-30-2.5M
Q1 '222022-03-31-3.3M
Q4 '212021-12-31-3.5M
Q3 '212021-09-30-2.7M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q4 '212021-12-310
Q3 '212021-09-300
Q2 '212021-06-300
Q1 '212021-03-310
Q4 '202020-12-310
Q3 '202020-09-300
Q2 '202020-06-300
Q1 '202020-03-314K
Q4 '192019-12-3137K
Q3 '192019-09-3024K
Q2 '192019-06-30191K
Q1 '192019-03-31106K
Q4 '182018-12-31116K
Q3 '182018-09-30109K
Q2 '182018-06-30135K
Q1 '182018-03-31157K
Q4 '172017-12-31165K
Q3 '172017-09-30147K
Q2 '172017-06-30203K
Q1 '172017-03-31175K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-1.7M
Q1 '262026-03-31-1.7M
Q4 '252025-12-31-2.5M
Q3 '252025-09-30-1.7M
Q2 '252025-06-30-1.6M
Q1 '252025-03-31-1.6M
Q4 '242024-12-31-2.4M
Q3 '242024-09-30-2.6M
Q2 '242024-06-30-1.3M
Q1 '242024-03-31-1.5M
Q4 '232023-12-31-1.9M
Q3 '232023-09-30-2.4M
Q2 '232023-06-30-3.2M
Q1 '232023-03-31-2.6M
Q4 '222022-12-31-3M
Q3 '222022-09-30-2M
Q2 '222022-06-30-2.6M
Q1 '222022-03-31-2.9M
Q4 '212021-12-31-3M
Q3 '212021-09-30-2.6M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-1.7M
Q1 '262026-03-31-1.7M
Q4 '252025-12-31-2.5M
Q3 '252025-09-30-1.7M
Q2 '252025-06-30-1.6M
Q1 '252025-03-31-1.6M
Q4 '242024-12-31-2.4M
Q3 '242024-09-30-2.6M
Q2 '242024-06-30-1.3M
Q1 '242024-03-31-1.5M
Q4 '232023-12-31-1.9M
Q3 '232023-09-30-2.4M
Q2 '232023-06-30-3.2M
Q1 '232023-03-31-2.6M
Q4 '222022-12-31-3M
Q3 '222022-09-30-2M
Q2 '222022-06-30-2.7M
Q1 '222022-03-31-2.9M
Q4 '212021-12-31-3M
Q3 '212021-09-30-2.7M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3012.1M
Q1 '262026-03-3110.8M
Q3 '252025-09-306.3M
Q2 '252025-06-305.1M
Q1 '252025-03-314.6M
Q3 '242024-09-302.8M
Q2 '242024-06-301.9M
Q1 '242024-03-311.7M
Q3 '232023-09-301.4M
Q2 '232023-06-301.4M
Q1 '232023-03-3120.2M
Q3 '222022-09-3017.8M
Q2 '222022-06-3017.7M
Q1 '222022-03-3117.1M
Q3 '212021-09-3017.1M
Q2 '212021-06-3017M
Q1 '212021-03-3116.6M
Q3 '162016-09-30230.5M
Q2 '162016-06-30230.3M
Q1 '162016-03-31230.3M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.64
Q1 '262026-03-31-0.91
Q4 '252025-12-31-1.29
Q3 '252025-09-30-1.48
Q2 '252025-06-30-1.85
Q1 '252025-03-31-2.33
Q4 '242024-12-31-3.09
Q3 '242024-09-30-4.16
Q2 '242024-06-30-5.34
Q1 '242024-03-31-6.98
Q4 '232023-12-31-5.80
Q3 '232023-09-30-4.64
Q2 '232023-06-30-3.02
Q1 '232023-03-31-0.64
Q4 '222022-12-31-0.66
Q3 '222022-09-30-0.71
Q2 '222022-06-30-0.70
Q1 '222022-03-31-0.76
Q4 '212021-12-31-0.75
Q3 '212021-09-30-0.69